Cargando…
Efficacy and Safety of Tamsulosin for the Treatment of Non-neurogenic Voiding Dysfunction in Females: A 8-Week Prospective Study
We evaluated the therapeutic effects of tamsulosin for women with non-neurogenic voiding dysfunction. Women who had voiding dysfunctions for at least 3 months were included. Inclusion criteria were age ≥18 yr, International Prostate Symptom Score (IPSS) of ≥15, and maximum flow rate (Q(max)) of ≥12...
Autores principales: | Lee, Kyu-Sung, Han, Deok Hyun, Lee, Young-Suk, Choo, Myung-Soo, Yoo, Tag Keun, Park, Heung Jae, Yoon, Hana, Jeong, Hyeon, Lee, Sun Ju, Kim, Hayoung, Park, Won Hee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800025/ https://www.ncbi.nlm.nih.gov/pubmed/20052356 http://dx.doi.org/10.3346/jkms.2010.25.1.117 |
Ejemplares similares
-
Risk Factors of Voiding Dysfunction and Patient Satisfaction After Tension-free Vaginal Tape Procedure
por: Park, Sungchan, et al.
Publicado: (2005) -
Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder
por: Kim, Sung-Eun, et al.
Publicado: (2012) -
Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Lee, Young-Suk, et al.
Publicado: (2018) -
Dermatologist and urologist? A neglected relationship in neurogenic voiding dysfunctions
por: Przydacz, Mikolaj, et al.
Publicado: (2017) -
Effects of Bladder Training and/or Tolterodine in Female Patients with Overactive Bladder Syndrome: A Prospective, Randomized Study
por: Song, Cheryn, et al.
Publicado: (2006)